136 related articles for article (PubMed ID: 1833779)
1. GR38032F, a serotonin 5-HT3 antagonist, fails to alter cocaine self-administration in rats.
Peltier R; Schenk S
Pharmacol Biochem Behav; 1991 May; 39(1):133-6. PubMed ID: 1833779
[TBL] [Abstract][Full Text] [Related]
2. Failure of ondansetron to block the discriminative or reinforcing stimulus effects of cocaine in the rat.
Lane JD; Pickering CL; Hooper ML; Fagan K; Tyers MB; Emmett-Oglesby MW
Drug Alcohol Depend; 1992 Jun; 30(2):151-62. PubMed ID: 1386019
[TBL] [Abstract][Full Text] [Related]
3. Effects of the 5-HT3 receptor antagonist, GR38032F, on raised dopaminergic activity in the mesolimbic system of the rat and marmoset brain.
Costall B; Domeney AM; Naylor RJ; Tyers MB
Br J Pharmacol; 1987 Dec; 92(4):881-94. PubMed ID: 2962686
[TBL] [Abstract][Full Text] [Related]
4. MDL 72222, ketanserin, and methysergide pretreatments fail to alter breaking points on a progressive ratio schedule reinforced by intravenous cocaine.
Lacosta S; Roberts DC
Pharmacol Biochem Behav; 1993 Jan; 44(1):161-5. PubMed ID: 8430119
[TBL] [Abstract][Full Text] [Related]
5. Differential effects of the 5-HT(2A) receptor antagonist M100907 and the 5-HT(2C) receptor antagonist SB242084 on cocaine-induced locomotor activity, cocaine self-administration and cocaine-induced reinstatement of responding.
Fletcher PJ; Grottick AJ; Higgins GA
Neuropsychopharmacology; 2002 Oct; 27(4):576-86. PubMed ID: 12377394
[TBL] [Abstract][Full Text] [Related]
6. Effects of chronic administration of ondansetron (GR38032F), a selective 5-HT3 receptor antagonist, on monoamine metabolism in mesolimbic and nigrostriatal dopaminergic neurons and on striatal D2-receptor binding.
Koulu M; Lappalainen J; Hietala J; Sjöholm B
Psychopharmacology (Berl); 1990; 101(2):168-71. PubMed ID: 2140903
[TBL] [Abstract][Full Text] [Related]
7. The effect of GR38032F, novel 5-HT3-receptor antagonist on gastric emptying in the guinea-pig.
Costall B; Gunning SJ; Naylor RJ; Tyers MB
Br J Pharmacol; 1987 Jun; 91(2):263-4. PubMed ID: 2955843
[TBL] [Abstract][Full Text] [Related]
8. Effect of a novel 5-hydroxytryptamine3-antagonist, GR38032F, on the 5-hydroxytryptamine-induced increase in carotid sinus nerve activity in rats.
Yoshioka M
J Pharmacol Exp Ther; 1989 Aug; 250(2):637-41. PubMed ID: 2527299
[TBL] [Abstract][Full Text] [Related]
9. Blockade of accumbens 5-HT3 receptor down-regulation by ondansetron administered during continuous cocaine administration.
King GR; Xiong Z; Ellinwood EH
Eur J Pharmacol; 1999 Jan; 364(2-3):79-87. PubMed ID: 9932709
[TBL] [Abstract][Full Text] [Related]
10. Effects of acute GR38032F (odansetron), a 5-HT3 receptor antagonist, on dopamine and serotonin metabolism in mesolimbic and nigrostriatal dopaminergic neurons.
Koulu M; Sjöholm B; Lappalainen J; Virtanen R
Eur J Pharmacol; 1989 Oct; 169(2-3):321-4. PubMed ID: 2530097
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the 5-HT3 receptor antagonist properties of ICS 205-930, GR38032F and zacopride.
Cohen ML; Bloomquist W; Gidda JS; Lacefield W
J Pharmacol Exp Ther; 1989 Jan; 248(1):197-201. PubMed ID: 2521513
[TBL] [Abstract][Full Text] [Related]
12. Effects of serotonin 5-HT1B receptor ligands on the cocaine- and food-maintained self-administration in rats.
Przegaliński E; Gołda A; Frankowska M; Zaniewska M; Filip M
Eur J Pharmacol; 2007 Mar; 559(2-3):165-72. PubMed ID: 17291490
[TBL] [Abstract][Full Text] [Related]
13. Serotonin 5-HT3 antagonists do not alter the discriminative stimulus properties of cocaine.
Paris JM; Cunningham KA
Psychopharmacology (Berl); 1991; 104(4):475-8. PubMed ID: 1780417
[TBL] [Abstract][Full Text] [Related]
14. Effect of 5-hydroxytryptamine on external carotid nerve activity and its blockade by GR38032F in anesthetized rats.
Yoshioka M; Ikeda T; Abe M; Togashi H; Saito H
Res Commun Chem Pathol Pharmacol; 1991 Oct; 74(1):39-45. PubMed ID: 1839326
[TBL] [Abstract][Full Text] [Related]
15. Effect of the 5-HT3 receptor antagonist, GR38032F, on responses to injection of a neurokinin agonist into the ventral tegmental area of the rat brain.
Hagan RM; Butler A; Hill JM; Jordan CC; Ireland SJ; Tyers MB
Eur J Pharmacol; 1987 Jun; 138(2):303-5. PubMed ID: 2442006
[No Abstract] [Full Text] [Related]
16. Long-term blockade of the expression of cocaine sensitization by ondansetron, a 5-HT(3) receptor antagonist.
King GR; Xiong Z; Douglass S; Ellinwood EH
Eur J Pharmacol; 2000 Apr; 394(1):97-101. PubMed ID: 10771040
[TBL] [Abstract][Full Text] [Related]
17. Role of serotonin (5-HT)2 receptors in cocaine self-administration and seeking behavior in rats.
Filip M
Pharmacol Rep; 2005; 57(1):35-46. PubMed ID: 15849375
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological properties of GR38032F, a novel antagonist at 5-HT3 receptors.
Butler A; Hill JM; Ireland SJ; Jordan CC; Tyers MB
Br J Pharmacol; 1988 Jun; 94(2):397-412. PubMed ID: 2969267
[TBL] [Abstract][Full Text] [Related]
19. Blockade of cocaine sensitization and tolerance by the co-administration of ondansetron, a 5-HT3 receptor antagonist, and cocaine.
King GR; Xiong Z; Ellinwood EH
Psychopharmacology (Berl); 1997 Mar; 130(2):159-65. PubMed ID: 9106914
[TBL] [Abstract][Full Text] [Related]
20. 5-HT3 receptor modulation of behavior during withdrawal from continuous or intermittent cocaine.
King GR; Joyner CM; Ellinwood EH
Pharmacol Biochem Behav; 1994 Mar; 47(3):399-407. PubMed ID: 8208757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
